Stay updated on Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Melanoma and MedlinePlus Genetics related topics were removed from the page's related topics section. This is a minor metadata change that does not alter the study details.
    Difference
    0.2%
    Check dated 2025-10-27T20:45:13.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Removed a MedlinePlus Genetics topic about Melanoma from the page.
    Difference
    0.2%
    Check dated 2025-10-20T14:23:40.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added MedlinePlus Genetics topic: Melanoma. No deletions.
    Difference
    0.2%
    Check dated 2025-10-13T11:51:32.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and operating status guidance, affecting transaction processing and inquiries. - Updated software version from v3.1.0 to v3.2.0.
    Difference
    3%
    Check dated 2025-10-06T07:49:07.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.1%
    Check dated 2025-09-29T03:50:16.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Removed a MedlinePlus Genetics topic focusing on melanoma, reducing the page’s coverage of that genetic-related melanoma topic.
    Difference
    0.2%
    Check dated 2025-09-22T00:25:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Ipilimumab Melanoma Immunotherapy Clinical Trial page.